However, as the tumor progresses, HCC cells often develop resistance to TGF-β growth-inhibitory and apoptotic effects through the activation of intracellular signals, such as the Epidermal Growth Receptor (EGFR) or the RAS/ERK pathways [6,7]. The gene discussed is TGFB1; the disease is neoplasm.